The FAK scaffold inhibitor C4 disrupts FAK-VEGFR-3 signaling and inhibits pancreatic cancer growth.

Oncotarget · 2013 · PMC3858551 · PMID 24142503

Europe PMC DOI

hedged sentence

0.0760

closest p · 1.5× alpha

0.0760

boldest claim

The sentences

did not reach statistical significanceP=0.076so close (0.05 < p ≤ 0.1)

These tumors were smaller than tumors in control group, though the difference did not reach statistical significance (P=0.076) (Figure 6B ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.